2012 IPO Outlook: U.S. May See Another Choppy IPO Market But Much Depends on Success of Highly Anticipated Social Media IPOs
NEW YORK, Dec. 27, 2011 /PRNewswire/ -- 2012 will be another turbulent year for the U.S. IPO market, according to a new survey of American transaction attorneys conducted by KCSA Strategic Communications, a leading integrated communications firm specializing in financial public relations, investor relations, social media and creative marketing services. KCSA conducted an in-depth survey of 50 securities attorneys whose firms advised on 70 percent of the initial public offerings listed on major U.S.

Zacks.com Reviews Restaurant Stocks for November 2011
CHICAGO, Dec. 1, 2011 /PRNewswire/ -- Zacks.com reviews restaurant stocks featured in the Industry Outlook Review. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Royal Dutch Shell plc: Notification of Transactions of Directors / Persons Discharging Managerial Responsibility ("PDMRS") and Connected Persons
LONDON, December 21, 2011 /PRNewswire/ -- Notification relating to a transaction notified in accordance with: DR 3.1.4 R(1)(a) Date of Notification:    20 December 2011 Today's Date:    21 December 2011 Name of Issuer:    Royal Dutch Shell plc Date of transaction:    16 December 2011 Name of Directors/PDMRs See names listed below. Nature of the transaction Rollover of dividends into Royal Dutch Shell plc shares RDSA, RDSB and RDS.A (as given below) under the Long-Term Incentive Plan, Performance Share Plan, Deferred Bonus Plan and Restricted Share plan. The values are as follows: Peter Voser           €    243,618.57 Malcolm Brinded       £    165,667.69 Simon Henry           £    77,498.68 Jeroen van der ...

World Vaccines Market 2011-2021
NEW YORK, Dec. 1, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: World Vaccines Market 2011-2021 Do you want to know how the vaccines industry and market will develop from 2011? Our new report shows you potential revenues to 2021, discussing opportunities and prospects. Our report gives you market forecasts to 2021 for vaccines in human healthcare.